These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25621137)

  • 21. Insulin glulisine in the management of diabetes.
    Yamada S
    Diabetes Metab Syndr Obes; 2009 Jul; 2():111-5. PubMed ID: 21437124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of type 1 diabetes mellitus with which localized insulin allergy was markedly alleviated by switching to insulin glulisine.
    Watanabe K; Kusunoki Y; Katsuno T; Nakae R; Matsuo T; Ochi F; Tokuda M; Akagami T; Miuchi M; Miyagawa J; Namba M
    Acta Diabetol; 2016 Oct; 53(5):845-8. PubMed ID: 26838553
    [No Abstract]   [Full Text] [Related]  

  • 23. Switching to Multiple Daily Insulin Injections in Children and Adolescents with Type 1 Diabetes: A Question of Standards.
    Al-Mendalawi MD
    Oman Med J; 2015 Jul; 30(4):307-8. PubMed ID: 26366269
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.
    Wojciechowski P; Niemczyk-Szechowska P; Olewińska E; Jaros P; Mierzejewska B; Skarżyńska-Duk J; Małecki MT; Ryś P
    Pol Arch Med Wewn; 2015; 125(3):141-51. PubMed ID: 25644227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.
    Joseph JJ; Donner TW
    Vasc Health Risk Manag; 2015; 11():107-16. PubMed ID: 25657589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rapid-acting insulin analogues insulin glulisine and insulin aspart on postprandial glycemic excursion with single bout of exercise in patients with type 2 diabetes.
    Tanaka N; Hiura Y
    Endocr J; 2015; 62(5):411-6. PubMed ID: 25739586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin.
    Begg DP; May AA; Mul JD; Liu M; D'Alessio DA; Seeley RJ; Woods SC
    Diabetes; 2015 Jul; 64(7):2457-66. PubMed ID: 25667307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study.
    Giorda CB; Ozzello A; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Lucisano G; Nicolucci A; Rossi MC;
    Acta Diabetol; 2015 Oct; 52(5):845-53. PubMed ID: 25670242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes.
    Inoue Y; Nakamura A; Kondo Y; Hamano K; Satoh S; Terauchi Y
    J Clin Pharmacol; 2015 Jul; 55(7):831-8. PubMed ID: 25677642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.
    Derosa G; Franzetti I; Querci F; Romano D; D'Angelo A; Maffioli P
    Diabetes Obes Metab; 2015 Jun; 17(6):554-559. PubMed ID: 25694300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.
    Klonoff D; Nayberg I; Rabbone I; Domenger C; Stauder U; Oualali H; Danne T
    J Diabetes Sci Technol; 2015 May; 9(3):625-31. PubMed ID: 25633967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycaemic load versus carbohydrate counting for insulin bolus calculation in patients with type 1 diabetes on insulin pump.
    Bozzetto L; Giorgini M; Alderisio A; Costagliola L; Giacco A; Riccardi G; Rivellese AA; Annuzzi G
    Acta Diabetol; 2015 Oct; 52(5):865-71. PubMed ID: 25697600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes.
    Thalange N; Deeb L; Iotova V; Kawamura T; Klingensmith G; Philotheou A; Silverstein J; Tumini S; Ocampo Francisco AM; Kinduryte O; Danne T
    Pediatr Diabetes; 2015 May; 16(3):164-76. PubMed ID: 25683037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injection technique practices in a population of Canadians with diabetes: results from a recent patient/diabetes educator survey.
    Berard L; Cameron B
    Can J Diabetes; 2015 Apr; 39(2):146-51. PubMed ID: 25623619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
    Bolli GB; Riddle MC; Bergenstal RM; Ziemen M; Sestakauskas K; Goyeau H; Home PD;
    Diabetes Obes Metab; 2015 Apr; 17(4):386-94. PubMed ID: 25641260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD.
    Chow LS; Chen H; Miller ME; Marcovina SM; Seaquist ER
    Diabetologia; 2015 Jun; 58(6):1160-6. PubMed ID: 25652389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations.
    Daniels GH; Hegedüs L; Marso SP; Nauck MA; Zinman B; Bergenstal RM; Mann JF; Derving Karsbøl J; Moses AC; Buse JB; Tuttle RM;
    Diabetes Obes Metab; 2015 May; 17(5):477-86. PubMed ID: 25656058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials.
    Kautzky-Willer A; Kosi L; Lin J; Mihaljevic R
    Diabetes Obes Metab; 2015 Jun; 17(6):533-540. PubMed ID: 25678212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metformin.
    Blevins T
    Expert Opin Drug Saf; 2015 May; 14(5):789-93. PubMed ID: 25789798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One center in Brussels has consistently had the lowest HbA1c values in the 4 studies (1994-2009) by the Hvidoere International Study Group on Childhood Diabetes: What are the "recipes"?
    Dorchy H
    World J Diabetes; 2015 Feb; 6(1):1-7. PubMed ID: 25685273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.